TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway

MLA

Linan Zhu, et al. “TIPE2 Suppresses Progression and Tumorigenesis of Esophageal Carcinoma via Inhibition of the Wnt/β-Catenin Pathway.” Journal of Translational Medicine, vol. 16, no. 1, Jan. 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12967-018-1383-0.

APA

Linan Zhu, Xudong Zhang, Xiaorui Fu, Zhaoming Li, Zhenchang Sun, Jingjing Wu, Xinhua Wang, Feng Wang, Xiangke Li, Songtao Niu, Mengjie Ding, Zhenzhen Yang, Wanqiu Yang, Meifeng Yin, Lei Zhang, & Mingzhi Zhang. (2018). TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway. Journal of Translational Medicine, 16(1), 1–10. https://doi.org/10.1186/s12967-018-1383-0

Chicago

Linan Zhu, Xudong Zhang, Xiaorui Fu, Zhaoming Li, Zhenchang Sun, Jingjing Wu, Xinhua Wang, et al. 2018. “TIPE2 Suppresses Progression and Tumorigenesis of Esophageal Carcinoma via Inhibition of the Wnt/β-Catenin Pathway.” Journal of Translational Medicine 16 (1): 1–10. doi:10.1186/s12967-018-1383-0.